|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 39/00 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| C07D 215/38 | (2006.01) | ||
| A61P 39/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| C07D 215/38 | (2013.01) |
| (11) | Number of the document | 3337486 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16839942.6 |
| Date of filing the European patent application | 2016-08-22 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/048054 |
| Date | 2016-08-22 |
| (87) | Number | WO 2017/035077 |
| Date | 2017-03-02 |
| (30) | Number | Date | Country code |
| 201562208223 P | 2015-08-21 | US |
| (72) |
BRADY, Todd , US
YOUNG, Scott , US
KINNEY, William, A. , US
MACDONALD, Susan , US
|
| (73) |
Aldeyra Therapeutics, Inc. ,
131 Hartwell Avenue
Suite 320, Lexington, MA 02421,
US
|
| (54) | DEUTERATED COMPOUNDS AND USES THEREOF |
| DEUTERATED COMPOUNDS AND USES THEREOF |